Article

The only thing that changed was the title. The job, the responsibilities, even the pay were exactly the same, but when the title was changed to director, the relationships, levels of trust, gossip and impediments to getting things done were all out of whack for a couple of months. This is a situation that takes more than simple explanations to fix.


Problem: Pharma and biotech companies are striving to reduce drug attrition rates within the drug discovery process.

Stephen Barnes, Ph.D., Professor of Pharmacology & Toxicology and Director of the Targeted Metabolomics and Proteomics Laboratory at the University of Alabama at Birmingham (UAB), talks about the changes taking place in the field of mass spectrometry (MS) as it migrates from the research lab to a clinical environment.










